4//SEC Filing
Allouche Cyril 4
Accession 0001479290-19-000002
CIK 0001479290other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 8:02 PM ET
Size
4.9 KB
Accession
0001479290-19-000002
Insider Transaction Report
Form 4
Allouche Cyril
Principal Financial Officer
Transactions
- Other
Common Stock
2018-12-31$17.11/sh+375$6,416→ 4,375 total
Footnotes (1)
- [F1]These shares were acquired by Mr. Allouche under the Issuer's 2014 Employee Stock Purchase Plan (the "Plan") on December 31, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Mr. Allouche purchased the maximum number of shares allowable under the Plan and Internal Revenue Code Section 423(b)(8) for the period ended December 31, 2018.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001744573
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 8:02 PM ET
- Size
- 4.9 KB